Rockefeller Financial Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
Rockefeller Financial Services's DGX Position: Q4 2017 in Review
Rockefeller Financial Services increased its Quest Diagnostics (DGX) stake by 741,981% in Q4 2017, buying an estimated $118M and bringing the position to 1,246,696 shares worth $123M. The position accounts for 1.94% of the portfolio, ranked #12.
Rockefeller Financial Services first reported a position in DGX in Q2 2013 and has held it in 18 quarters since. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.
- Rockefeller Financial Services held 1,246,696 shares of Quest Diagnostics worth $123M as of Q4 2017.
- Rockefeller Financial Services bought 1,246,528 Quest Diagnostics shares in Q4 2017, an estimated $118M.
- Quest Diagnostics made up 1.94% of Rockefeller Financial Services's portfolio in Q4 2017, its #12 holding.
- Rockefeller Financial Services first reported a position in Quest Diagnostics in Q2 2013 and has held it in 18 quarters since.
- 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.
Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.